CUE - Cue Biopharma Inc
Previous close
0.721
0 0%
Share volume: 43,448
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.72
0.00
0.00%
Summary score
24%
Profitability
25%
Dept financing
10%
Liquidity
62%
Performance
17%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-21.74%
Return on assets
-15.14%
Return on sales
-6304.1%
Return on invested capital
174.19%
Total debt ratio
28.26%
Debt ratio change over timeo
-0.95%
Current Ratio
5.15%
Quick Ratio
5.1%
Cash Position Ratio
4.8%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-32.95%
Return on assets
-20.19%
Return on sales
-752.66%
Return on invested capital
210.94%
Total debt ratio
39.81%
Debt ratio change over timeo
-0.81%
Current Ratio
3.14%
Quick Ratio
3.14%
Cash Position Ratio
2.96%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-41.1%
Return on assets
-23.48%
Return on sales
-737.8%
Return on invested capital
140.18%
Total debt ratio
44.32%
Debt ratio change over time
-0.77%
Current Ratio
2.47%
Quick Ratio
2.47%
Cash Position Ratio
2.27%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-104.51%
Return on assets
-102.93%
Return on sales
1090.1%
Return on invested capital
22.4%
Total debt ratio
-94.51%
Debt ratio change over time
-0.95%
Current Ratio
-0.46%
Quick Ratio
-0.5%
Cash Position Ratio
-0.49%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CUE | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -21.74% | 13.79% | 34.47% | 7.43% |
| Return on assets | -15.14% | 2.76% | 3.15% | 5.62% |
| Return on sales | -6304.1% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 174.19% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 40% | 60% | 58% |
| Total debt ratio | 28.26% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -0.95% | 308.97% | -6.99% | 1.18% |
| Dept financing | 8% | 50% | 25% | 7% |
| Current Ratio | 3.14% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 3.14% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 2.96% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 10% | 22% | 51% |
| Short-term ratios | CUE | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -32.95% | 13.77% | 13.25% | 3.8% |
| Return on assets | -20.19% | 2.43% | 1.89% | 3.09% |
| Return on sales | -752.66% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 210.94% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 65% | 59% | 58% |
| Total debt ratio | 39.81% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -0.81% | 46.38% | -72.08% | 1.51% |
| Dept financing | 11% | 50% | 25% | 7% |
| Current Ratio | 3.14% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 3.14% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 2.96% | 0.36% | 1.28% | 2.93% |
| Liquididy | 56% | 12% | 31% | 75% |